SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.
Address
9715 KEY WEST AVENUE
ROCKVILLE, MD 20850
Founded
2005
Number of Employees
652
Website
http://www.supernus.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)